A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis

Gut
Stephan MiehlkeAlex Straumann

Abstract

To investigate the efficacy and safety of two different budesonide formulations (effervescent tablet for orodispersible use (BET) and viscous suspension (BVS)) with different daily dosages for short-term treatment of eosinophilic oesophagitis (EoE). Adults with active EoE (n=76) randomly received 14 days' treatment with either BET 2×1 mg/day (BET1, n=19) or BET 2×2 mg/day (BET2, n=19), or BVS 2×5 mL (0.4 mg/mL)/day (BVS, n=19) or placebo (n=19) in a double-blind, double-dummy fashion, with a 2-week follow-up. Primary end point was histological remission (mean of <16 eosinophils/mm(2 )hpf). Secondary end points included endoscopy score, dysphagia score, drug safety and patient's preference for drug formulation. Histological remission occurred in 100%, 94.7% and 94.7% of budesonide (BET1, BET2, BVS, respectively) and in 0% of placebo recipients (p<0.0001). The improvement in total endoscopic intensity score was significantly higher in the three budesonide groups compared with placebo. Dysphagia improved in all groups at the end of treatment; however, improvement of dysphagia persisted only in those treated with BET1 (p=0.0196 vs placebo). There were no serious adverse events. Local fungal infection (stained fungi) occurred in two...Continue Reading

References

Feb 2, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Elizabeth T SchaeferSandeep K Gupta
Feb 11, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Karin DilgerJürgen Finke
Jul 7, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ganapathy A PrasadNicholas J Talley
Feb 1, 2011·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Alex StraumannHans-Uwe Simon
Apr 12, 2011·The Journal of Allergy and Clinical Immunology·Chris A LiacourasSeema S Aceves
Oct 25, 2011·The Journal of Allergy and Clinical Immunology·Petr HruzUNKNOWN Swiss EoE study group
Dec 31, 2011·The Journal of Allergy and Clinical Immunology·Jonathan M SpergelChris A Liacouras
Apr 6, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jeffrey A AlexanderNicholas J Talley
May 23, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Hannah P KimEvan S Dellon
Sep 12, 2012·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·B D van RhijnA J Bredenoord
Sep 26, 2012·Nature Reviews. Gastroenterology & Hepatology·Alex Straumann, Alain M Schoepfer
Apr 10, 2013·The American Journal of Gastroenterology·Evan S DellonUNKNOWN American College of Gastroenterology
Sep 17, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Evan S DellonMichael D Kappelman
Jul 6, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Evan S DellonNicholas J Shaheen

❮ Previous
Next ❯

Citations

Feb 19, 2016·Digestive Diseases and Sciences·Caitlin M BurkEvan S Dellon
Mar 18, 2016·Clinical and Translational Gastroenterology·Manish B Singla, Fouad J Moawad
Feb 19, 2016·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·S NennstielC Schlag
May 8, 2016·The American Journal of Medicine·Robert T KavittMichael F Vaezi
May 22, 2016·Expert Review of Clinical Immunology·Tanbeena Imam, Sandeep K Gupta
May 19, 2016·Expert Review of Clinical Pharmacology·Susan HuaNicholas J Talley
Oct 28, 2016·Annals of the New York Academy of Sciences·Fouad J MoawadMirna Chehade
Dec 13, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Cary C CottonEvan S Dellon
Feb 6, 2017·Asia Pacific Allergy·Hamish PhilpottFrancis Thien
Mar 28, 2017·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ikuo HiranoEvan S Dellon
Nov 1, 2017·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·E SternI Hirano
Aug 15, 2017·Expert Review of Gastroenterology & Hepatology·Alfredo J LucendoLaura Arias-González
Feb 9, 2016·World Journal of Gastrointestinal Pharmacology and Therapeutics·Aakash Goyal, Edaire Cheng
Jun 1, 2018·Expert Opinion on Emerging Drugs·Robert D Pesek, Sandeep K Gupta
Jan 30, 2018·Journal of Leukocyte Biology·Jennifer Armbruster-LeeAmali E Samarasinghe
Oct 19, 2017·F1000Research·Sandy Durrani, Marc Rothenberg
Nov 1, 2018·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·L KiaI Hirano
Oct 6, 2017·Clinical and Translational Gastroenterology·Dustin A CarlsonJohn E Pandolfino
Jun 16, 2017·Clinical and Translational Gastroenterology·Swathi EluriEvan S Dellon
Feb 2, 2019·Current Treatment Options in Gastroenterology·Quan M Nhu, Fouad J Moawad
Mar 13, 2019·British Journal of Hospital Medicine·Stephen E Attwood
Jul 23, 2019·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·Swathi EluriEvan S Dellon
Dec 18, 2019·Expert Review of Clinical Immunology·Alfredo J Lucendo
Jan 8, 2019·Journal of Clinical Gastroenterology·Simon WeidlichChristoph Schlag
Feb 18, 2020·Korean journal of family medicine·Amir MariAfif Yaccob
May 5, 2020·Annals of Internal Medicine·David A Katzka
Jun 14, 2017·Digestive Diseases and Sciences·Cary C CottonEvan S Dellon
Jun 23, 2020·Expert Review of Gastroenterology & Hepatology·Aditi ReddyArvind R Murali
Jul 18, 2020·Alimentary Pharmacology & Therapeutics·Emilio J Laserna-MendietaUNKNOWN EUREOS EoE CONNECT Research group
Feb 24, 2016·Alimentary Pharmacology & Therapeutics·U von ArnimP Malfertheiner
Jan 23, 2018·Current Treatment Options in Gastroenterology·Ronak Vashi Patel, Ikuo Hirano
May 26, 2018·Annals of the New York Academy of Sciences·Deepa T PatilRhonda K Yantiss
Aug 8, 2020·Annals of the New York Academy of Sciences·Nielsen Q Fernandez-BeckerJennifer L Horsley-Silva
Dec 6, 2017·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·T M RungeE S Dellon
Oct 12, 2017·Journal of Gastroenterology·Hamish Philpott, Evan S Dellon
Feb 8, 2018·Expert Opinion on Investigational Drugs·James HaridyEvan D Newnham
Mar 20, 2018·European Journal of Pediatrics·Mery Munoz-Persy, Alfredo J Lucendo
Mar 20, 2019·Journal of Pediatric Gastroenterology and Nutrition·Jacob RobsonLaura Bennett-Murphy
Mar 25, 2019·Clinical Reviews in Allergy & Immunology·Nirmala Gonsalves
Jul 29, 2019·Drugs·Willemijn E de RooijAlbert J Bredenoord
Oct 27, 2018·Frontiers in Medicine·Elisa Gomez TorrijosJoan Bartra

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
sedation
biopsy

Clinical Trials Mentioned

NCT02280616

Software Mentioned

Addplan
Interactive Web Response System
SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.